Substituted aromatic compounds and pharmaceutical compositions thereof
AssigneePharmaceutique Ingenew Inc.
InventorLyne GAGNON
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmaceutique Ingenew Inc.
InventorLyne GAGNON
Estimating the term…
Compounds of Formula I or II, methods of preparation and of use thereof. Formula I has a core aromatic group with substituents as follows: Formula (I) wherein G1 is —(CH2)nC(R1)(R2)OH, —(CH2)n; —CHO, —(CH2)nC(O)NR1R2, —(CH2)nCH (R1)NR1R2, —(CH2)nC(O)OR3, —(CH2)n—CH(R1)O—R3, or —(CH2)nC(O)R3; G2 and G4 are independently H, OH, F, or Cl, where G2 can also be NH2; G3 and G5 are independently (H, F, Cl, OH, —(CH2)n-optionally substituted heterocycle, —(CH2)n-optionally substituted phenyl, —(CH2)nC3H5, optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, —C(O)—R3, or CH(OH)—R3; and G6 is H, F, Cl, OH, —(CH2)n-optionally substituted heterocycle, —(CH2)n-optionally substituted phenyl, or (CH2)nCOOH, wherein ⋅n is an integer selected from 0 to 5, ⋅R1 and R2 are independently selected from H and optionally substituted C1-C6 alkyl group, and ⋅R3 is an optionally substituted C1-C6 alkyl group or when present on G1 forms a lactone with the core aromatic group, or a pharmaceutically acceptable salt thereof.
A compound according to Formula I having a core aromatic group with substituents as follows:
-43. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.